77 related articles for article (PubMed ID: 34048122)
1. Molecular basis for catabolism of the abundant metabolite
Backman LR; Huang YY; Andorfer MC; Gold B; Raines RT; Balskus EP; Drennan CL
Elife; 2020 Mar; 9():. PubMed ID: 32180548
[TBL] [Abstract][Full Text] [Related]
2. Metabolic engineering strategy for synthetizing trans-4-hydroxy-L-proline in microorganisms.
Zhang Z; Liu P; Su W; Zhang H; Xu W; Chu X
Microb Cell Fact; 2021 Apr; 20(1):87. PubMed ID: 33882914
[TBL] [Abstract][Full Text] [Related]
3. Proline: Mother Nature's cryoprotectant applied to protein crystallography.
Pemberton TA; Still BR; Christensen EM; Singh H; Srivastava D; Tanner JJ
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):1010-8. PubMed ID: 22868767
[TBL] [Abstract][Full Text] [Related]
4. (2S,4R)-4-hydroxyproline(4-nitrobenzoate): strong induction of stereoelectronic effects via a readily synthesized proline derivative. Crystallographic observation of a correlation between torsion angle and bond length in a hyperconjugative interaction.
Pandey AK; Yap GP; Zondlo NJ
J Org Chem; 2014 May; 79(9):4174-9. PubMed ID: 24720652
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobic substituent effects on proline catalysis of aldol reactions in water.
Zhao Q; Lam YH; Kheirabadi M; Xu C; Houk KN; Schafmeister CE
J Org Chem; 2012 May; 77(10):4784-92. PubMed ID: 22500641
[TBL] [Abstract][Full Text] [Related]
6. Phenyl-substituted aminomethylene-bisphosphonates inhibit human P5C reductase and show antiproliferative activity against proline-hyperproducing tumour cells.
Forlani G; Sabbioni G; Ragno D; Petrollino D; Borgatti M
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1248-1257. PubMed ID: 34107832
[TBL] [Abstract][Full Text] [Related]
7. Structural Insight into the Catalytic Mechanisms of an L-Sorbosone Dehydrogenase.
Li D; Deng Z; Hou X; Qin Z; Wang X; Yin D; Chen Y; Rao Y; Chen J; Zhou J
Adv Sci (Weinh); 2023 Oct; 10(30):e2301955. PubMed ID: 37679059
[TBL] [Abstract][Full Text] [Related]
8. Amino acid metabolism genes associated with immunotherapy responses and clinical prognosis of colorectal cancer.
Peng X; Zheng T; Guo Y; Zhu Y
Front Mol Biosci; 2022; 9():955705. PubMed ID: 35992263
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.
Gao J; Hao Y; Piao X; Gu X
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269824
[TBL] [Abstract][Full Text] [Related]
10. Structural studies of yeast Δ(1)-pyrroline-5-carboxylate dehydrogenase (ALDH4A1): active site flexibility and oligomeric state.
Pemberton TA; Srivastava D; Sanyal N; Henzl MT; Becker DF; Tanner JJ
Biochemistry; 2014 Mar; 53(8):1350-9. PubMed ID: 24502590
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyproline in animal metabolism, nutrition, and cell signaling.
Hu S; He W; Wu G
Amino Acids; 2022 Apr; 54(4):513-528. PubMed ID: 34342708
[TBL] [Abstract][Full Text] [Related]
12. Structure, function, and mechanism of proline utilization A (PutA).
Liu LK; Becker DF; Tanner JJ
Arch Biochem Biophys; 2017 Oct; 632():142-157. PubMed ID: 28712849
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the stereospecific inhibition of the dual proline/hydroxyproline catabolic enzyme ALDH4A1 by trans-4-hydroxy-L-proline.
Bogner AN; Stiers KM; McKay CM; Becker DF; Tanner JJ
Protein Sci; 2021 Aug; 30(8):1714-1722. PubMed ID: 34048122
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of prolines and hydroxyprolines binding to the l-glutamate-γ-semialdehyde dehydrogenase active site of bifunctional proline utilization A.
Campbell AC; Bogner AN; Mao Y; Becker DF; Tanner JJ
Arch Biochem Biophys; 2021 Feb; 698():108727. PubMed ID: 33333077
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of substrate selectivity of Δ(1)-pyrroline-5-carboxylate dehydrogenase (ALDH4A1): semialdehyde chain length.
Pemberton TA; Tanner JJ
Arch Biochem Biophys; 2013 Oct; 538(1):34-40. PubMed ID: 23928095
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
